Cargando…
Clinical predictive value of naïve and memory T cells in advanced NSCLC
Currently, there is no sensitive prognostic biomarker to screen out benefit patients from the non-benefit population in advanced non-small cell lung cancer patients (aNSCLCs). The 435 aNSCLCs and 278 normal controls (NCs) were recruited. The percentages and absolute counts (AC) of circulating naïve...
Autores principales: | Zhang, Guan, Liu, Aqing, Yang, Yanjie, Xia, Ying, Li, Wentao, Liu, Yunhe, Zhang, Jing, Cui, Qian, Wang, Dong, Liu, Xu, Guo, Yongtie, Chen, Huayu, Yu, Jianchun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478592/ https://www.ncbi.nlm.nih.gov/pubmed/36119064 http://dx.doi.org/10.3389/fimmu.2022.996348 |
Ejemplares similares
-
The Predictive Value of Changes in the Absolute Counts of Peripheral Lymphocyte Subsets for Progression and Prognosis in Breast Cancer Patients
por: Liu, Aqing, et al.
Publicado: (2022) -
The clinical value of the changes of peripheral lymphocyte subsets absolute counts in patients with non-small cell lung cancer
por: Xia, Ying, et al.
Publicado: (2020) -
The DC–T cell axis is an effective target for the treatment of non‐small cell lung cancer
por: Wang, Shuangcui, et al.
Publicado: (2023) -
Recent Advances and Future Perspective of DC-Based Therapy in NSCLC
por: van der Hoorn, Iris A. E., et al.
Publicado: (2021) -
Computer Modeling of Clonal Dominance: Memory-Anti-Naïve and Its Curbing by Attrition
por: Castiglione, Filippo, et al.
Publicado: (2019)